MolNFT v1 · #86665 · protein
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)
4BDG: “Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (CHK2)”. X-ray diffraction. MolNFT v1 #86665 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 4BDG
- Type
- protein
- Length
- 286 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- O96017
Structure
x-ray diffraction · 1 distinct chain.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 286 | — | O96017 |
Compared structures
- 4BDG · Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase… · the same entry in another collection · chain A against A, TM-score 1.00
- O96017 · AlphaFold monomer V2.0 prediction for SERINE/THREONINE-protein kinase CHK2 (O96017) · a predicted model of the same protein · chain A against A, TM-score 0.85
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O96017
- Elsewhere: RCSB PDB 4BDG · PDBe 4BDG · UniProt O96017
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.